lindsley
l
pierc
role
cell
resist
theiler
viru
infect
microbi
pathogenesi
intracerebr
infect
osnj
mice
theiler
viru
result
acut
enceph
subsequ
viru
clearanc
absenc
spinal
cord
demyelin
contrast
infect
sjlj
mice
result
acut
enceph
viru
persist
immunemedi
demyelin
experi
examin
role
tcell
subset
vivo
immun
respons
theiler
viru
resist
mice
deplet
tcell
subset
monoclon
antibodi
mab
direct
pantcel
marker
class
class
irestrict
cell
result
increas
frequenc
paralysi
death
result
acut
enceph
neuropatholog
studi
day
infect
demonstr
promin
necrosi
primarili
pyramid
layer
hippocampu
thalamu
mice
deplet
tcell
subset
immunosuppress
infect
mice
analysi
spinal
cord
section
day
infect
demonstr
small
demyelin
lesion
rel
devoid
inflammatori
cell
even
though
viru
antigen
could
detect
immunocytochemistri
cell
import
resist
infect
theiler
viru
osnj
mice
howev
subsequ
spinal
cord
demyelin
extent
observ
suscept
mice
depend
presenc
viru
antigen
persist
compet
cellular
immun
respons
intracerebr
infect
osnj
mice
theiler
murin
encephalomyel
viru
tmev
picornaviru
result
acut
enceph
character
infiltr
inflammatori
cell
within
mening
hippocampu
thalamu
hypothalamu
lesser
extent
cerebr
cortex
within
day
infect
mononuclear
inflammatpri
infiltr
consist
cell
macrophag
b
cell
occasion
plasma
cell
typic
monophas
immun
respons
viru
antigen
detect
primarili
within
neuron
deep
structur
brain
e
pyramid
neuron
hippocampu
thalamu
hypothalamu
striatum
tempor
lobe
cerebr
cortex
occasion
anterior
horn
cell
spinal
cord
viru
titer
central
nervou
system
cn
peak
day
infect
clear
rapidli
mice
within
week
infect
mice
show
neurolog
abnorm
earli
infect
clinic
patholog
sign
chronic
demyelin
develop
spinal
cord
contrast
intracerebr
infect
suscept
sjlj
mice
tmev
caus
biphas
diseas
character
acut
enceph
follow
chronic
demyelin
spinal
cord
viru
antigen
detect
neuron
brain
acut
diseas
oligodendrocyt
astrocyt
macrophag
express
viru
antigen
viru
rna
spinal
cord
chronic
phase
diseas
infecti
viru
detect
cn
throughout
cours
infect
long
year
intens
inflammatori
respons
consist
primarili
cell
persist
primarili
spinal
cord
patholog
condit
induc
chronic
persist
infect
similar
multipl
sclerosi
thu
make
excel
anim
model
human
virusinduc
demyelin
disord
reason
differ
suscept
resist
tm
evinduc
chronic
demyelin
diseas
unknown
evid
immun
respons
play
role
osnj
congen
mice
b
k
haplotyp
abl
clear
viru
infect
demyelin
develop
wherea
mice
ident
background
p
v
q
f
r
haplotyp
persist
viru
infect
demyelin
diseas
develop
differ
suscept
resist
map
region
locu
major
histocompat
complex
mhc
indic
class
irestrict
immun
respons
critic
process
genet
cross
congen
mice
differ
mhc
haplotyp
ident
background
show
f
progeni
deriv
resist
suscept
mice
exhibit
minim
demyelin
indic
background
resist
inherit
domin
trait
data
consist
hypothesi
immunolog
basi
resist
determin
effici
present
viru
antigen
immun
system
result
local
clearanc
viru
subsequ
absenc
demyelin
previou
studi
demonstr
immunosuppress
subleth
gamma
irradi
render
normal
resist
mice
suscept
tmevinduc
demyelin
irradi
mice
also
increas
inflamm
surround
anterior
horn
cell
spinal
cord
earli
paralysi
increas
frequenc
death
primarili
third
week
infect
addit
mice
deplet
natur
killer
nk
cell
vivo
treatment
mab
polyclon
antiserum
anti
develop
diffus
enceph
mening
paralysi
die
indic
nk
cell
also
critic
effector
protect
tmevinduc
enceph
gray
matter
diseas
spinal
cord
contrast
treatment
resist
mice
igg
effort
deplet
earli
b
cell
effect
patholog
featur
clinic
variabl
similar
result
obtain
certain
strain
bcelldefici
mice
exhibit
xid
mutat
indic
immunoglobulin
play
littl
role
protect
resist
mice
tmev
infect
purpos
present
experi
examin
role
tcell
subset
immun
respons
tmev
resist
mice
mice
treat
mab
effort
deplet
interfer
function
tcell
subset
determin
precis
contribut
cell
resist
tmev
diseas
immunocytochemistri
detect
viru
antigen
use
determin
deplet
tcell
subset
predispos
viru
antigen
persist
result
tcell
subset
deplet
monoclon
antibodi
mab
mab
effici
vivo
deplet
lymphocyt
determin
inject
two
normal
mice
intraperiton
total
mg
normal
rat
igg
nrigg
period
mgday
blood
specimen
drawn
weekli
assay
presenc
lymphocyt
flowcytometr
analysi
mice
treat
mab
demonstr
substanti
decreas
lymphocyt
respect
fig
convers
treatment
mab
minim
effect
percentag
lymphocyt
respect
lymphocyt
remain
deplet
day
posttreat
day
percentag
lymphocyt
increas
still
remain
untreat
control
lymphocyt
deplet
day
posttreat
increas
normal
day
therefor
treatment
mab
deplet
respect
cell
type
level
remain
abnorm
day
experi
previous
publish
experi
demonstr
deplet
cell
vivo
treatment
mab
result
vivo
tcell
deplet
use
mab
sjlj
mice
also
report
previous
agglutin
sheep
erythrocyt
srbc
mice
treat
mab
tcell
subset
determin
degre
immunosuppress
mice
treat
mab
tcell
subset
inject
p
srbc
tcelldepend
antigen
day
viru
infect
assay
haemaggiutin
done
day
viru
infect
respect
tabl
mice
treat
control
nrigg
normal
hamster
nham
igg
develop
antibodi
respons
srbc
result
titer
approxim
eight
serial
doubl
dilut
contrast
mice
treat
mab
consist
demonstr
undetect
low
titer
agglutin
whether
mab
given
time
viru
infect
day
infect
similarli
mice
treat
mab
combin
mab
also
undetect
low
agglutin
titer
contrast
mice
treat
mab
show
essenti
normal
agglutin
respons
document
partial
immunosuppress
persist
throughout
cours
experi
day
viru
infect
mab
treatment
anim
immun
srbc
day
mab
treatment
continu
show
undetect
low
agglutin
titer
determin
role
tcell
subset
resist
tmev
infect
osnj
mice
treat
p
immunosuppress
dose
mab
either
prior
viru
infect
day
earli
phase
diseas
day
demyelin
begin
develop
spinal
cord
suscept
mice
treatment
mice
ltg
hamster
mab
earli
infect
result
mice
show
either
paralysi
death
compar
none
five
untreat
mice
tabl
none
mice
treat
equival
tabl
treatment
rat
mab
mice
develop
earli
paralysi
die
none
mice
treat
control
nrigg
show
diseas
major
differ
note
death
paralysi
infect
mice
treat
mice
show
diseas
respect
howev
paralysi
death
occur
sooner
mice
treat
compar
mab
tabl
confirm
synergist
role
cell
mice
treat
simultan
mab
seven
mice
die
approxim
day
infect
mice
paralys
prior
death
experi
schedul
termin
day
tmev
infect
possibl
determin
treatment
would
result
delay
paralysi
death
differ
effect
observ
infect
mice
treat
mab
begin
day
infect
death
occur
approxim
week
infect
six
mice
treat
mab
howev
paralysi
death
observ
mab
given
independ
indic
phase
diseas
either
tcell
subset
could
mediat
resist
diseas
deplet
subset
result
death
paralysi
death
observ
osnj
mice
treat
control
antisera
day
infect
detail
patholog
analysi
perform
spinal
cord
brain
infect
mice
treat
mab
surviv
schedul
termin
experi
day
infect
increas
degre
anterior
horn
cell
necrosi
inflamm
neuron
inflamm
brain
observ
mice
treat
mab
compar
mice
receiv
nrigg
tabl
major
patholog
differ
detect
degre
necrosi
inflamm
pyramid
layer
hippocampu
thalamu
fig
control
mice
treat
nrigg
major
brain
show
mild
inflammatori
chang
hippocampu
contrast
mice
immunosuppress
treatment
lesser
extent
mab
show
promin
necrosi
hippocampu
deep
within
thalamu
howev
tabl
use
plasticembed
section
demyelin
lesion
observ
mice
treat
mab
control
fig
differ
minor
equal
degre
demyelin
inflamm
observ
normal
suscept
strain
mice
result
mab
treatment
inconclus
major
mice
die
prior
schedul
sacrific
day
howev
earlier
analysi
mice
day
tabl
fail
demonstr
increas
demyelin
determin
late
immunosuppress
would
result
demyelin
mice
treat
mab
begin
day
infect
analys
patholog
abnorm
day
tabl
increas
demyelin
inflamm
seen
spinal
cord
mice
result
mab
inconclus
one
six
mice
surviv
mous
show
small
number
demyelin
lesion
spinal
cord
show
evid
enceph
interest
treatment
mab
begin
day
infect
result
increas
total
brain
score
reflect
neuron
necrosi
inflamm
deep
structur
brain
viru
antigen
product
mice
treat
mab
tcell
subset
immunocytochem
situ
hybrid
studi
indic
strong
correl
local
viru
replic
area
patholog
chang
osnj
mice
lack
patholog
abnorm
strongli
correl
effici
viru
clearanc
determin
deplet
tcell
subset
would
predispos
viru
antigen
persist
day
infect
serial
spinal
cord
section
mice
previous
perfus
trump
fix
stain
viru
antigen
spinal
cord
section
virusinfect
mice
treat
control
nrigg
virusantigenposit
cell
contrast
mice
studi
treat
mab
show
virusantigenposit
cell
spinal
cord
white
matter
fig
mani
virusantigenposit
cell
associ
small
area
demyelin
modest
cellular
infiltr
consist
primarili
macrophag
result
also
consist
observ
made
other
infect
balbc
mice
homozyg
respect
nude
gene
nunu
balbc
mice
similar
mice
resist
tmevinduc
demyelin
howev
balbc
nunu
mice
tlymphocyt
immunodefici
inject
tmev
develop
paralysi
death
associ
small
focal
area
demyelin
spinal
cord
indic
tmev
lytic
oligodendrocyt
without
contribut
tlymphocyt
immun
system
contrast
none
normal
balbc
mice
becam
clinic
ill
die
immunoperoxidas
studi
demonstr
infect
balbc
nunu
mice
exhibit
heavi
virusantigen
load
anterior
horn
cell
spinal
cord
occasion
oligodendrocyt
express
viru
antigen
spinal
cord
white
matter
result
use
tcell
deplet
mice
other
use
balbc
nunu
mice
support
hypothesi
inabl
clear
viru
infect
brain
spinal
cord
gray
matter
result
deficit
tcell
function
howev
recent
data
suggest
antibodi
may
also
play
role
decreas
level
infecti
viru
cn
treatment
infect
balbc
nunu
mice
mab
viral
protein
result
decreas
number
demyelin
lesion
augment
cn
remyelin
observ
cell
play
role
resist
tmev
infect
provid
interest
paradox
cell
also
consid
import
product
immunemedi
demyelin
immunocompet
sjlj
mice
experi
use
seri
therapeut
strategi
includ
cyclophosphamid
antilymphocyt
serum
cyclosporin
mab
immun
respons
gene
prod
uct
mab
indic
immunosuppress
decreas
number
extent
demyelin
lesion
sjlj
mice
contrast
deplet
immunoglobulin
complement
result
augment
diseas
indic
case
antibodi
may
protect
recent
experi
laboratori
indic
vivo
treatment
tumour
necrosi
factor
alpha
result
mark
reduct
demyelin
lesion
suscept
sjlj
mice
resolv
paradox
propos
resist
mice
develop
earli
protect
immun
respons
consist
n
k
cell
cell
direct
viru
antigen
clear
viru
brain
spinal
cord
gray
matter
deficit
nk
function
antigen
present
suscept
sjlj
mice
unabl
clear
viru
allow
subsequ
infect
oligodendrocyt
astrocyt
macrophag
spinal
cord
white
matter
may
lyse
chronic
infect
previous
prime
cytotox
lymphocyt
direct
viru
antigen
virusinduc
host
antigen
persist
tm
ev
presenc
antivir
cytotox
lymphocyt
may
result
viru
mutant
aris
infect
evad
antivir
cytotox
lymphocyt
viru
daniel
da
strain
tmev
use
experi
strain
origin
obtain
j
r
lehrich
associ
univers
chicago
grown
plaqueform
unitsml
babi
hamster
cell
antibodi
cell
hybridoma
synthes
rat
antibodi
isotyp
obtain
american
type
cultur
collect
mab
recogn
monomorph
determin
molecul
respect
hamster
mab
direct
mous
obtain
j
blueston
univers
chicago
mab
obtain
ascit
fluid
use
vivo
therapi
stain
cell
flow
cytometri
prepar
ascit
fluid
x
hybridoma
cell
inject
balbc
mice
prime
irradi
subleth
gy
tcelldefici
balbc
nude
mice
ascit
fluid
contain
mab
purifi
affin
chromatographi
mous
antirat
igg
column
mab
antihamst
igg
column
mab
fow
cytometri
two
hundr
microlit
suspens
wash
cell
peripher
blood
incub
ice
min
equal
volum
dilut
purifi
ascit
fluid
mgml
contain
mab
wash
cell
stain
biotinconjug
mous
antirat
igg
vector
laboratori
burlingam
california
crossreact
mous
ig
incub
ice
anoth
min
cell
wash
twice
stain
min
ml
streptavidinfluorescein
isothiocyan
conjug
dilut
analys
flow
cytometri
fac
v
becton
dickinson
san
jose
california
evalu
degre
background
stain
lymphocyt
stain
substitut
primari
antibodi
nrigg
anim
experiment
protocol
osnj
femal
mice
week
old
jackson
laboratori
bar
harbor
main
innocul
intracerebr
x
plaqueform
unit
tmev
vehicl
mice
treat
p
mg
mg
mg
nrlgg
nhamslgg
either
time
viru
inocul
day
infect
anim
monitor
daili
presenc
paralysi
death
day
schedul
termin
experi
patholog
analysi
mice
perfus
trump
fix
phosphatebuff
formaldehyd
contain
glutaraldehyd
ph
spinal
cord
process
provid
pm
thick
glycol
methacrylateembed
section
stain
modifi
erichrom
stain
detail
morpholog
analysi
perform
coron
spinal
cord
section
anim
result
analysi
spinal
cord
section
experiment
group
patholog
score
base
gray
matter
inflamm
mening
inflamm
demyelin
obtain
anim
describ
previous
quadrant
everi
spinal
cord
section
grade
presenc
absenc
patholog
featur
maximum
patholog
score
indic
presenc
inflamm
demyelin
everi
quadrant
spinal
cord
section
one
mous
data
present
deviat
brain
perfus
anim
remov
skull
cut
three
coron
section
embed
paraffin
cerebellum
brain
stem
hippocampu
striatum
cerebr
cortex
mening
corpu
callosum
grade
independ
fourpoint
scale
presenc
inflamm
necrosi
patholog
abnorm
minim
inflamm
cell
per
highpow
field
hpf
moder
inflamm
inflammatori
cell
per
hpf
intens
inflamm
inflammatori
cell
per
hpf
earli
necrosi
intens
inflamm
widespread
necrosi
tissu
score
variou
area
ad
provid
total
brain
score
maximum
sheep
erythrocyt
agglutin
assay
serum
sampl
treat
mice
assay
igm
hemagglutin
srbc
determin
whether
p
treatment
mab
tcell
subset
suppress
humor
immun
respons
irrelev
antigen
anim
given
srbc
p
inject
day
sacrific
assay
sera
mice
store
assay
one
time
igm
hemagglutin
multipl
serial
dilut
sera
made
yl
dilut
place
microtit
plate
dilut
pack
srbc
phosphatebuff
albumin
made
ul
ad
well
mixtur
incub
min
spun
min
rpm
agglutin
read
determin
igm
titer
immunocytochemistri
detect
viru
antigen
immunoperoxidas
studi
spinal
cord
tissu
block
store
phosphat
buffer
rins
tri
buffer
mm
hydroxylamin
ph
treat
dimethyl
sulphoxid
buffer
h
quickfrozen
isopentan
chill
liquid
nitrogen
tenmicromet
cryostat
section
cut
transfer
gelatinco
glass
slide
frozen
section
spinal
cord
deparaffin
brain
section
mice
perfus
trump
fix
reduc
sodium
borohydrid
tri
buffer
mm
hydroxylamin
ph
refix
glacial
acet
acid
section
immunostain
polyclon
antiserum
purifi
tmev
strain
da
virion
avidinbiotin
immunoperoxidas
techniqu
vector
laboratori
burlingam
california
slide
develop
solut
hankery
reagent
pphenylenediamineprocatechol
polysci
warrington
pennsylvania
counterstain
hematoxylin
